Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05253703 · ClinicalTrials.gov registry record · NA

Immersive Virtual Reality Bicycling for Healthy Adults

A NA study of Healthy, sponsored by Rutgers, The State University of New Jersey.

Completed
Registry status
NA
Development phase
50
Enrollment target
1
Study location

NCT05253703: Completed NA study of Healthy, sponsored by Rutgers, The State University of New Jersey.

NCT05253703 is a NA study of Healthy that has completed, run by Rutgers, The State University of New Jersey. The registered enrollment target is 50 participants, below the 647-participant average among 1,090 other Healthy trials with a reported enrollment target (92% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05253703, a NA study of Healthy, has completed, sponsored by Rutgers, The State University of New Jersey.

COMPLETED
Registry status
NA
Development phase
50 participants
Enrollment target
1
Study location

Study Summary

This study has four objectives about healthy younger and older adults during immersive virtual reality bicycling: Determine the effect of visual feedback and competition for younger healthy adults during virtual bicycling on user experience, motivation, enjoyment, perception of effort, and neuromuscular and cardiovascular intensity Determine the effect of visual feedback and competition for older healthy adults during virtual bicycling on user experience, motivation, enjoyment, perception of effort, and neuromuscular and cardiovascular intensity Compare younger and older during visual feedback and competition bicycling in terms of: user experience, motivation, enjoyment, perception of effort, neuromuscular and cardiovascular intensity Determine if attention differs in visual feedback bicycling compared to competition bicycling for younger and older healthy adults

Primary Outcome

Bicycling cadence collected continuously (1 value per second, 1 Hz)

Conditions Studied

Interventions

  • OTHER Virtual reality bicycling

Study Locations (1)

New Jersey

  • Rutgers School of Health Professions - Newark

Trial Details

FieldValue
Enrollment Target 50 participants
Start Date 2022-02-16
Est. Completion 2022-06-07
Phase NA

What the finished NCT05253703 record still lists

NCT05253703 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 50 participants, a relatively small participant target, below the 647-participant average among 1,090 other Healthy trials with a reported enrollment target (92% lower).

The record links to 1 condition, with Healthy appearing as the primary indexed condition, and to 1 intervention - of which Virtual reality bicycling is the first listed.

NCT05253703 reports a single indexed study location in New Jersey.

Frequently Asked Questions

What is clinical trial NCT05253703 about?

NCT05253703 is a clinical study titled "Immersive Virtual Reality Bicycling for Healthy Adults". This study has four objectives about healthy younger and older adults during immersive virtual reality bicycling: Determine the effect of visual feedback and competition for younger healthy adults during virtual bicycling on user experience, motivation, enjoyment, perception of effort, and neuromus...

What is the current status of trial NCT05253703?

This trial is currently completed. It is a NA study. The enrollment target is 50 participants. The study started on 2022-02-16. Estimated completion is 2022-06-07.

What conditions does trial NCT05253703 study?

This clinical trial studies the following conditions: Healthy.

What interventions are being tested in trial NCT05253703?

The interventions under investigation include: Virtual reality bicycling (OTHER).

Who is sponsoring clinical trial NCT05253703?

This trial is sponsored by Rutgers, The State University of New Jersey, which has 413 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05253703 being conducted?

This trial has 1 study location across New Jersey. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Healthy

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT05253703's enrollment target sits among peer trials

50 448th of 1090 higher than 618 of 1,090 other Healthy trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Healthy trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00409435 · 50 participants · Phase 2

    A Study of Pyridostigmine in Postural Tachycardia Syndrome

  • NCT01202305 · 50 participants

    The Use of Lymph Node Biopsies to Support HIV Pathogenesis Studies

  • NCT01225913 · 50 participants · Phase 4

    Mechanism(s) of Airflow Limitation During Exacerbation of Asthma

  • NCT01746836 · 50 participants · Phase 2

    Ponatinib Hydrochloride as Second Line Therapy in Treating Patients With Chronic Myeloid Leukemia in Chronic Phase Resistant or Intolerant to Imatinib Mesylate, Dasatinib, or Nilotinib

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT05253703, the US trial registry maintained by the National Library of Medicine. NCT05253703 (small enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.